Background and aimsThe application of chemical fungicides is the rst strategy to control plant fungal diseases. This approach is highly polluting for the environment and affects human health. Arti cial introduction of bene cial rhizobacteria into the soil can be an economical and practical way to control phytopathogenic fungi in commercial greenhouses. Here, we recount the travel of a rare Actinomycete (Amycolatopsis strain 1119) from a maize eld to a commercial cucumber greenhouse.
Methods and resultsCulturable bacteria from rhizosphere and bulk soils of dicot and monocot crops were isolated and screened. About 20% of the representative colonies showed Actinomycetes appearance. 106 Actinomycetes that had antagonistic activity against Phytophthora capsici and were able to produce IAA were selected for further analysis. Two Streptomyces strains (432 and 615) and 2 Amycolatopsis strains (3513 and 1119) that showed a positive effect on plant growth in greenhouse conditions were selected to evaluate for biocontrol potential. Strains 432, 3513, 615 and 1119 controlled incidence of the damping-off by 65%, 42%, 83% and 100% respectively. Application of strain 1119 under commercial greenhouse conditions resulted in an increase in fruit yield (20%) and a decrease in fruit nitrate content (70%). Increased antioxidant enzymes activity and increased LOX and APX transcription and also, increased expression of two genes PR1-1a and GLU (SAR genes) showed that strain 1119 could induce both ISR and SAR in cucumber without pathogen exposure.
ConclusionOur results demonstrate that the Amycolatopsis strain 1119, has a great potential to enter the market as a bio-stimulator.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.